Cancer - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutations in oncogenes and tumor suppressor genes lead to uncontrolled cell proliferation. Oncogenes promote cell growth, while mutations in tumor suppressor genes prevent normal cell cycle arrest, allowing cancer cells to evade apoptosis.

• Secondary mechanism: Tumor microenvironment alterations, including angiogenesis and immune evasion. Angiogenesis provides the growing tumor with nutrients and oxygen, while cancer cells modulate the immune response to avoid detection and destruction.

• Key complication: Metastasis, the spread of cancer cells to distant organs, is facilitated by changes in cell adhesion molecules and proteolytic enzymes that degrade extracellular matrix components, leading to poor prognosis and increased mortality.

Patient Profile

Demographics:

67-year-old female, retired school teacher

History:

• Key past medical history: Diagnosed with stage IV pancreatic cancer, type 2 diabetes, hypertension, and history of deep vein thrombosis

• Current medications: Metformin, Lisinopril, Warfarin, Chemotherapy regimen (FOLFIRINOX)

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and jaundice

• Key symptoms: Nausea, vomiting, weight loss, fatigue, anorexia, and dark urine

• Vital signs: Blood pressure 86/54 mmHg, Heart rate 128 bpm, Respiratory rate 24 breaths per minute, Temperature 38.5°C (101.3°F), Oxygen saturation 88% on room air

Section 1

Initial assessment findings reveal the patient in acute distress, exhibiting signs of systemic compromise likely due to her metastatic pancreatic cancer and concurrent comorbidities. The jaundice and severe abdominal pain suggest possible biliary obstruction, commonly seen in pancreatic cancer due to tumor invasion into the bile duct. On physical examination, the abdomen is distended and tender, particularly in the right upper quadrant, with diminished bowel sounds indicating possible paralytic ileus or bowel obstruction. Her hypotension, tachycardia, and elevated respiratory rate suggest hypovolemic shock, possibly exacerbated by dehydration from persistent nausea and vomiting. The fever and leukocytosis point to a probable infection, possibly cholangitis or sepsis, requiring immediate intervention.

Laboratory results reveal critical imbalances: elevated liver enzymes (AST, ALT, alkaline phosphatase), significantly increased bilirubin levels, and markedly low albumin, reflecting hepatic dysfunction. Her INR is elevated at 3.5, indicating a risk for bleeding due to impaired liver function and Warfarin therapy. Renal function tests show acute kidney injury with elevated creatinine and BUN, likely prerenal from dehydration and hypotension. Arterial blood gases indicate a respiratory alkalosis with hypoxemia, consistent with her low oxygen saturation and increased respiratory effort. Imaging via CT scan confirms a large pancreatic mass with liver metastases and significant biliary dilation, further complicating her clinical picture.

The urgent need for management includes fluid resuscitation to address hypovolemia, broad-spectrum antibiotics to treat potential sepsis, and consideration of biliary decompression procedures such as ERCP to relieve obstruction. The patient's condition demands careful monitoring in an intensive care setting, with vigilant assessment of her hemodynamic status, coagulation profile, and renal function. The complexity of her presentation calls for advanced clinical reasoning to balance her anticoagulation therapy with the risk of bleeding, manage her pain effectively, and address the metabolic derangements while navigating the challenges posed by her advanced cancer and comorbidities.

Section 2

As the multidisciplinary team initiates aggressive intervention, the patient exhibits a noticeable change in her status. Despite the administration of intravenous fluids aimed at correcting hypovolemia, her blood pressure remains persistently low at 85/50 mmHg, with a heart rate now climbing to 132 beats per minute. Her respiratory rate has increased to 34 breaths per minute, with labored breathing and oxygen saturation declining to 88% on a non-rebreather mask, indicating worsening hypoxemia. The patient's mental status has deteriorated; she is now only responsive to painful stimuli, suggesting a decrease in cerebral perfusion and possible progression to septic shock.

New diagnostic results reveal an escalating white blood cell count of 22,000/mm³, further supporting the suspicion of a systemic infection. Blood cultures obtained prior to antibiotic administration return positive for Gram-negative bacilli, likely implicating cholangitis secondary to biliary obstruction. Additionally, repeat liver function tests show worsening hepatic impairment, with bilirubin levels now reaching 18 mg/dL, and liver enzymes continuing to rise. The patient's acute kidney injury has progressed, with creatinine levels surging to 3.2 mg/dL, necessitating urgent renal consultation for potential renal replacement therapy.

In response to these developments, the care team must reevaluate and intensify the treatment strategy. The initiation of vasopressor support is considered to stabilize her hemodynamics, while the infectious disease specialist recommends adjusting antibiotic therapy based on culture sensitivities. Given the significant biliary obstruction, an emergent endoscopic retrograde cholangiopancreatography (ERCP) is now prioritized to relieve obstruction and prevent further septic deterioration. This complex clinical scenario requires the team to continuously balance the risks and benefits of each intervention, monitor for potential complications of advanced cancer and comorbid conditions, and adapt the care plan to align with the patient's dynamic and critical condition.

Section 3

As the medical team initiates vasopressor support with norepinephrine to stabilize the patient's hemodynamics, they observe an initial modest improvement in her blood pressure, which now reads 95/55 mmHg. However, despite this intervention, her heart rate remains elevated at 128 beats per minute, and her oxygen saturation struggles to maintain above 90% even with increased ventilatory support. The respiratory therapy team is called to assess the need for intubation and mechanical ventilation, given the patient's labored breathing and persistent hypoxemia. The critical care nurse notes that the patient's skin is cool and mottled, indicating ongoing peripheral perfusion issues, while her urine output has decreased to less than 20 mL/hour, confirming the progression of acute kidney injury.

The emergent endoscopic retrograde cholangiopancreatography (ERCP) is performed with the goal of relieving the biliary obstruction. During the procedure, the gastroenterology team successfully decompresses the biliary system by placing a stent, which immediately results in a visible reduction in jaundice. Post-ERCP, the patient shows slight clinical improvement with a decrease in serum bilirubin levels to 15 mg/dL within 24 hours. However, the patient's condition remains precarious as her renal function further deteriorates, with creatinine peaking at 4.0 mg/dL, prompting the nephrology team to initiate continuous renal replacement therapy (CRRT) to manage fluid overload and toxin accumulation.

Despite the interventions, the patient develops a new complication: acute respiratory distress syndrome (ARDS), likely secondary to sepsis and the systemic inflammatory response. A chest X-ray reveals bilateral pulmonary infiltrates, and arterial blood gas analysis indicates worsening hypoxemia with a PaO2/FiO2 ratio of 150. The critical care team adjusts the ventilator settings to a lung-protective strategy, emphasizing the need for low tidal volumes and higher positive end-expiratory pressure (PEEP) to improve oxygenation while minimizing further lung injury. This case now requires meticulous coordination among the multidisciplinary team, focusing on titrating interventions based on the patient's evolving status, closely monitoring for potential complications, and adapting the treatment plan to optimize her chances of recovery amidst the escalating complexities of her condition.

Section 4

As the critical care team continues to manage the patient's complex condition, they focus on her evolving respiratory status in light of the newly diagnosed acute respiratory distress syndrome (ARDS). Despite adjustments to the ventilator settings, the patient's oxygenation remains suboptimal, with repeat arterial blood gases showing a PaO2 of 55 mmHg and PaCO2 of 60 mmHg, indicating the development of hypercapnia. Her oxygen saturation fluctuates between 85% and 88%, despite an FiO2 of 0.8, and the patient's work of breathing remains visibly labored. The respiratory therapy team, alongside the intensivist, reassesses the mechanical ventilation parameters, deciding to increase the PEEP to 15 cm H2O in an effort to recruit collapsed alveoli and improve gas exchange. The critical care nurse continuously monitors the patient's hemodynamics, noticing a subtle increase in blood pressure to 100/60 mmHg, suggesting a transient improvement in perfusion, although tachycardia persists with a heart rate of 125 beats per minute.

Additionally, new diagnostic results provide further insight into the patient's deteriorating condition. A repeat computed tomography (CT) scan of the chest reveals widespread ground-glass opacities consistent with worsening ARDS and possible superimposed pneumonia. Blood cultures drawn earlier return positive for gram-negative rods, leading to the urgent initiation of broad-spectrum antibiotics, including piperacillin-tazobactam and vancomycin, to target potential sources of infection. The patient's inflammatory markers, including C-reactive protein and procalcitonin, remain significantly elevated, underscoring the ongoing systemic inflammatory response.

Despite these efforts, the patient's renal function continues to decline, compounded by the hemodynamic challenges of maintaining adequate perfusion while managing fluid status in the context of ARDS. The nephrology team intensifies CRRT settings to optimize fluid removal and solute clearance. The multidisciplinary team remains vigilant, recognizing the delicate balance required to stabilize the patient without precipitating further complications. They convene to reassess the treatment strategy, considering potential escalation to extracorporeal membrane oxygenation (ECMO) as a last resort if conventional measures fail to achieve adequate oxygenation. As the team navigates these clinical challenges, they remain focused on evidence-based interventions and meticulous monitoring, acknowledging the precarious nature of the patient's condition and the critical need for coordinated care.

Section 5

As the critical care team continues their vigilant monitoring, a significant change in the patient's status becomes evident. Despite the increased PEEP and aggressive antibiotic therapy, the patient's respiratory condition further deteriorates. Her oxygen saturation drops to 82%, and her respiratory rate increases to 36 breaths per minute, indicating worsening respiratory distress. The intensivist orders an urgent bedside ultrasound, revealing bilateral pleural effusions that are likely contributing to her compromised respiratory mechanics. In light of these findings, the team decides to perform a therapeutic thoracentesis to relieve pressure on the lungs and improve ventilation.

Concurrently, the patient's hemodynamics begin to destabilize. Her blood pressure drops to 85/45 mmHg, and her heart rate escalates to 135 beats per minute, indicating progression towards shock. The critical care nurse notes cool, clammy skin and delayed capillary refill, suggesting impaired perfusion. Laboratory results show worsening acidosis with an arterial blood pH of 7.25 and a base deficit of -8, reflecting a mixed metabolic and respiratory acidosis. Lactate levels rise to 4.5 mmol/L, raising concerns about tissue hypoxia. The team initiates fluid resuscitation with balanced crystalloids to support hemodynamics while cautiously avoiding fluid overload in the presence of ARDS.

As these developments unfold, the nephrology team reports a further decline in kidney function, with serum creatinine rising to 3.8 mg/dL and urine output dropping to less than 0.3 mL/kg/hr. Given the patient's deteriorating multi-system status and refractory hypoxemia, the multidisciplinary team escalates discussions about the potential initiation of ECMO. The decision-making process involves weighing the risks and benefits of ECMO in the context of her critical condition, while continuing to optimize current interventions and closely monitor her response. The team remains committed to a collaborative approach, recognizing the complexity and urgency of the patient's evolving clinical picture.